Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treating skin cancer with topical cream.
Micali G, Lacarrubba F, Dinotta F, Massimino D, Nasca MR. Micali G, et al. Expert Opin Pharmacother. 2010 Jun;11(9):1515-27. doi: 10.1517/14656566.2010.481284. Expert Opin Pharmacother. 2010. PMID: 20408746 Review.
The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns.
Suppa M, Altomare G, Cannavò SP, Capizzi R, Catricalà C, Colombo E, Fargnoli MC, Fossati B, Frascione P, Lisi P, Santini M, Scalvenzi M, Peris K; Italian investigators for the Euromelanoma prevention campaign. Suppa M, et al. Int J Dermatol. 2014 Jun;53(6):699-706. doi: 10.1111/j.1365-4632.2012.05783.x. Epub 2012 Dec 11. Int J Dermatol. 2014. PMID: 23230843
Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L, Peris K, Longo C, Calvieri S, Frascione P, Parodi A, Eibenschuz L, Bottoni U, Pellacani G; Actinic Keratosis - TReatment Adherence INitiative (AK-TRAIN) study group. Neri L, et al. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):93-107. doi: 10.1111/jdv.15142. Epub 2018 Jul 8. J Eur Acad Dermatol Venereol. 2019. PMID: 29920789
Emerging topical drugs for the treatment of rosacea.
Dall'Oglio F, Nasca MR, Micali G. Dall'Oglio F, et al. Among authors: micali g. Expert Opin Emerg Drugs. 2021 Mar;26(1):27-38. doi: 10.1080/14728214.2021.1887138. Epub 2021 Feb 18. Expert Opin Emerg Drugs. 2021. PMID: 33596752 Review.
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy.
Gualdi G, Porreca A, Amoruso GF, Atzori L, Calzavara-Pinton P, De Tursi M, Buduo AD, Marino PD, Fabroncini G, Fantini F, Fargnoli MC, Giannotta G, Lacarruba F, Lotesoriere A, Merli M, Micali G, Paradisi A, Puviani M, Quaglino P, Rongioletti F, Rubatto M, Sbano P, Scalvenzi M, Soglia S, Sollima L, Villani A, Nicola MD, Amerio P. Gualdi G, et al. Among authors: micali g. Clin Dermatol. 2021 Sep-Oct;39(5):911-919. doi: 10.1016/j.clindermatol.2021.05.015. Epub 2021 May 27. Clin Dermatol. 2021. PMID: 34785022 Free PMC article.
Management of Advanced Invasive Melanoma: New Strategies.
Villani A, Scalvenzi M, Micali G, Lacarrubba F, Fornaro L, Martora F, Potestio L. Villani A, et al. Among authors: micali g. Adv Ther. 2023 Aug;40(8):3381-3394. doi: 10.1007/s12325-023-02555-5. Epub 2023 Jun 12. Adv Ther. 2023. PMID: 37306810 Free PMC article. Review.
495 results